← Leaderboards
Matthew C. Zimmerman
University Of Nebraska Lincoln
$2,881,222
Attributed
$2,881,222
Total exposure
7
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $607.8K · FY2008–14$1M$750K$500K$250K$0
'08
'09
'10
'11
'12
'13
'14
Funding mix
By agency
NIH$2,881,222 · 7
By mechanism
R01$1,820,121 · 1
P20$1,061,101 · 6
Top collaborators
No co-investigators on record.
Most similar at University Of Nebraska Lincoln
Same institution · by research overlap
- Andrzej Rajca$3,374,726
Others in their field
Top investigators on “Source”
- Richard A Gibbs · Baylor College Of Medicine$285,393,445
- David Heimbrook · Leidos Biomedical Research, Inc.$233,184,481
- Robert B Gagosian · Consortium For Ocean Leadership, Inc$232,495,072
- Jeffrey P Krischer · University Of South Florida$224,745,020
- Albert Lazzarini · California Institute Of Technology$202,317,285
- Charles Mattias Mountain · Association Of Universities For Research In Astronomy, Inc.$155,571,437
Research focus
SourceOrganNeuronsHeart FailureCardiovascular SystemCardiovascular DiseasesNeuraxisNeurogenic HypertensionMediatingSignal TransductionAntioxidantsHypertensionLeadGene TransferBlood - Brain Barrier AnatomyAngiotensin IiSuperoxidesProteinsFree RadicalsAdenoviral-MediatedBiologyLocationMitochondriaBiochemical
Grant awards (11)
Mitochondrial Redox Systems in Neurogenic Hypertension$360,187
R01 · FY2014 · HL · contact PI
Mitochondrial Redox Systems in Neurogenic Hypertension$349,896
R01 · FY2013 · HL · contact PI
Mitochondrial Redox Systems in Neurogenic Hypertension$367,538
R01 · FY2012 · HL · contact PI
Mitochondrial Redox Systems in Neurogenic Hypertension$371,250
R01 · FY2011 · HL · contact PI
A NANOZYME ANTIOXIDANT THERAPY FOR THE TREATMENT OF ANGIOTENSIN II-DEPENDANT HYP$223,081
P20 · FY2011 · RR · contact PI
ELECTRON PARAMAGNETIC RESONANCE (EPR) SPECTROSCOPY FACILITY$13,468
P20 · FY2011 · RR · contact PI
Mitochondrial Redox Systems in Neurogenic Hypertension$371,250
R01 · FY2010 · HL · contact PI
A NANOZYME ANTIOXIDANT THERAPY FOR THE TREATMENT OF ANGIOTENSIN II-DEPENDANT HYP$225,335
P20 · FY2010 · RR · contact PI
A NANOZYME ANTIOXIDANT THERAPY FOR THE TREATMENT OF ANGIOTENSIN II-DEPENDANT HYP$221,574
P20 · FY2009 · RR · contact PI
ROLE OF MITOCHONDRIAL-PRODUCED ROS IN NEUROGENIC HYPERTENSION$166,344
P20 · FY2009 · RR · contact PI
ROLE OF MITOCHONDRIAL-PRODUCED ROS IN NEUROGENIC HYPERTENSION$211,299
P20 · FY2008 · RR · contact PI